nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Topotecan—lung cancer	0.0584	0.142	CbGbCtD
Tadalafil—CYP3A4—Gefitinib—lung cancer	0.0534	0.13	CbGbCtD
Tadalafil—CYP3A4—Teniposide—lung cancer	0.0518	0.126	CbGbCtD
Tadalafil—CYP3A4—Vinorelbine—lung cancer	0.0412	0.1	CbGbCtD
Tadalafil—PDE5A—pulmonary artery—lung cancer	0.0345	0.547	CbGeAlD
Tadalafil—CYP3A4—Crizotinib—lung cancer	0.0327	0.0796	CbGbCtD
Tadalafil—CYP3A4—Erlotinib—lung cancer	0.0316	0.0768	CbGbCtD
Tadalafil—CYP3A4—Paclitaxel—lung cancer	0.0289	0.0703	CbGbCtD
Tadalafil—CYP3A4—Irinotecan—lung cancer	0.0285	0.0694	CbGbCtD
Tadalafil—CYP3A4—Vinblastine—lung cancer	0.0254	0.0617	CbGbCtD
Tadalafil—CYP3A4—Etoposide—lung cancer	0.0228	0.0556	CbGbCtD
Tadalafil—CYP3A4—Docetaxel—lung cancer	0.0209	0.0508	CbGbCtD
Tadalafil—CYP3A4—Doxorubicin—lung cancer	0.0156	0.0379	CbGbCtD
Tadalafil—PDE11A—epithelium—lung cancer	0.0127	0.202	CbGeAlD
Tadalafil—PDE5A—respiratory system—lung cancer	0.0058	0.092	CbGeAlD
Tadalafil—PDE5A—epithelium—lung cancer	0.00485	0.0769	CbGeAlD
Tadalafil—PDE5A—lung—lung cancer	0.00308	0.0488	CbGeAlD
Tadalafil—PDE5A—lymph node—lung cancer	0.00211	0.0334	CbGeAlD
Tadalafil—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000347	0.00337	CbGpPWpGaD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000342	0.00332	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—ITGB1—lung cancer	0.000334	0.00325	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—COL4A2—lung cancer	0.000334	0.00325	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PTHLH—lung cancer	0.000332	0.00323	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000328	0.00319	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GIPR—lung cancer	0.000325	0.00316	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ADCY1—lung cancer	0.000325	0.00316	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PPP2R1B—lung cancer	0.000316	0.00308	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—ANXA1—lung cancer	0.000313	0.00304	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SDC4—lung cancer	0.000304	0.00295	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PTHLH—lung cancer	0.000302	0.00293	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—DUSP3—lung cancer	0.000298	0.00289	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—APP—lung cancer	0.000296	0.00288	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RHEB—lung cancer	0.000292	0.00284	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—MMP1—lung cancer	0.000291	0.00283	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—ANXA1—lung cancer	0.000284	0.00276	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—APOA1—lung cancer	0.000279	0.00271	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—GRM8—lung cancer	0.000277	0.00269	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—APP—lung cancer	0.000269	0.00262	CbGpPWpGaD
Tadalafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000269	0.00261	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SKI—lung cancer	0.000268	0.00261	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MMP1—lung cancer	0.00026	0.00253	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000258	0.0025	CbGpPWpGaD
Tadalafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000256	0.00249	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CG—lung cancer	0.000255	0.00247	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—EGF—lung cancer	0.000252	0.00245	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—APOA1—lung cancer	0.000249	0.00242	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000245	0.00238	CbGpPWpGaD
Tadalafil—Gastritis—Doxorubicin—lung cancer	0.000244	0.000578	CcSEcCtD
Tadalafil—Pain—Cisplatin—lung cancer	0.000244	0.000578	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000244	0.000576	CcSEcCtD
Tadalafil—Vomiting—Vinorelbine—lung cancer	0.000243	0.000574	CcSEcCtD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000242	0.00235	CbGpPWpGaD
Tadalafil—Renal failure—Methotrexate—lung cancer	0.000242	0.000572	CcSEcCtD
Tadalafil—Rash—Vinorelbine—lung cancer	0.000241	0.000569	CcSEcCtD
Tadalafil—Dermatitis—Vinorelbine—lung cancer	0.00024	0.000569	CcSEcCtD
Tadalafil—Hypotension—Paclitaxel—lung cancer	0.00024	0.000567	CcSEcCtD
Tadalafil—Headache—Vinorelbine—lung cancer	0.000239	0.000565	CcSEcCtD
Tadalafil—Syncope—Docetaxel—lung cancer	0.000239	0.000565	CcSEcCtD
Tadalafil—Conjunctivitis—Methotrexate—lung cancer	0.000239	0.000565	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—lung cancer	0.000239	0.000565	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—lung cancer	0.000239	0.000565	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—CREBBP—lung cancer	0.000236	0.00229	CbGpPWpGaD
Tadalafil—Sweating—Methotrexate—lung cancer	0.000236	0.000557	CcSEcCtD
Tadalafil—Palpitations—Docetaxel—lung cancer	0.000236	0.000557	CcSEcCtD
Tadalafil—Paraesthesia—Etoposide—lung cancer	0.000235	0.000556	CcSEcCtD
Tadalafil—Haematuria—Methotrexate—lung cancer	0.000234	0.000554	CcSEcCtD
Tadalafil—Loss of consciousness—Docetaxel—lung cancer	0.000234	0.000554	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000234	0.000553	CcSEcCtD
Tadalafil—Dyspnoea—Etoposide—lung cancer	0.000233	0.000552	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PXN—lung cancer	0.000233	0.00226	CbGpPWpGaD
Tadalafil—Somnolence—Etoposide—lung cancer	0.000233	0.00055	CcSEcCtD
Tadalafil—Cough—Docetaxel—lung cancer	0.000233	0.00055	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—lung cancer	0.000233	0.00055	CcSEcCtD
Tadalafil—Insomnia—Paclitaxel—lung cancer	0.000232	0.000549	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—lung cancer	0.000232	0.000548	CcSEcCtD
Tadalafil—Hypersensitivity—Irinotecan—lung cancer	0.000232	0.000548	CcSEcCtD
Tadalafil—Convulsion—Docetaxel—lung cancer	0.000231	0.000546	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—AVP—lung cancer	0.00023	0.00224	CbGpPWpGaD
Tadalafil—Paraesthesia—Paclitaxel—lung cancer	0.00023	0.000545	CcSEcCtD
Tadalafil—Hypertension—Docetaxel—lung cancer	0.00023	0.000544	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—lung cancer	0.00023	0.000543	CcSEcCtD
Tadalafil—Dyspnoea—Paclitaxel—lung cancer	0.000229	0.000541	CcSEcCtD
Tadalafil—Somnolence—Paclitaxel—lung cancer	0.000228	0.00054	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GRP—lung cancer	0.000228	0.00222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKR1C1—lung cancer	0.000228	0.00222	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—OXTR—lung cancer	0.000228	0.00222	CbGpPWpGaD
Tadalafil—Arthralgia—Docetaxel—lung cancer	0.000227	0.000537	CcSEcCtD
Tadalafil—Myalgia—Docetaxel—lung cancer	0.000227	0.000537	CcSEcCtD
Tadalafil—Chest pain—Docetaxel—lung cancer	0.000227	0.000537	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PIK3CG—lung cancer	0.000227	0.00221	CbGpPWpGaD
Tadalafil—Nausea—Vinorelbine—lung cancer	0.000227	0.000536	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—lung cancer	0.000226	0.000534	CcSEcCtD
Tadalafil—Dyspepsia—Paclitaxel—lung cancer	0.000226	0.000534	CcSEcCtD
Tadalafil—Asthenia—Irinotecan—lung cancer	0.000226	0.000534	CcSEcCtD
Tadalafil—Fatigue—Etoposide—lung cancer	0.000226	0.000534	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000225	0.000533	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—EGF—lung cancer	0.000224	0.00218	CbGpPWpGaD
Tadalafil—Pain—Etoposide—lung cancer	0.000224	0.000529	CcSEcCtD
Tadalafil—Constipation—Etoposide—lung cancer	0.000224	0.000529	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PIK3CD—lung cancer	0.000224	0.00217	CbGpPWpGaD
Tadalafil—Dry mouth—Docetaxel—lung cancer	0.000222	0.000525	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000222	0.000525	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—lung cancer	0.000222	0.000525	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000222	0.000524	CcSEcCtD
Tadalafil—Fatigue—Paclitaxel—lung cancer	0.000221	0.000523	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—ALB—lung cancer	0.000221	0.00215	CbGpPWpGaD
Tadalafil—Haemorrhage—Methotrexate—lung cancer	0.000221	0.000522	CcSEcCtD
Tadalafil—Asthenia—Gemcitabine—lung cancer	0.00022	0.00052	CcSEcCtD
Tadalafil—Pain—Paclitaxel—lung cancer	0.000219	0.000519	CcSEcCtD
Tadalafil—Constipation—Paclitaxel—lung cancer	0.000219	0.000519	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—lung cancer	0.000219	0.000518	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—lung cancer	0.000218	0.000515	CcSEcCtD
Tadalafil—Oedema—Docetaxel—lung cancer	0.000218	0.000515	CcSEcCtD
Tadalafil—Pruritus—Gemcitabine—lung cancer	0.000217	0.000513	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—lung cancer	0.000216	0.000512	CcSEcCtD
Tadalafil—Infection—Docetaxel—lung cancer	0.000216	0.000511	CcSEcCtD
Tadalafil—Diarrhoea—Irinotecan—lung cancer	0.000215	0.000509	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—lung cancer	0.000214	0.000506	CcSEcCtD
Tadalafil—Shock—Docetaxel—lung cancer	0.000214	0.000506	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—GNG11—lung cancer	0.000213	0.00207	CbGpPWpGaD
Tadalafil—Nervous system disorder—Docetaxel—lung cancer	0.000213	0.000505	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—lung cancer	0.000213	0.000503	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—lung cancer	0.000213	0.000503	CcSEcCtD
Tadalafil—Tachycardia—Docetaxel—lung cancer	0.000212	0.000502	CcSEcCtD
Tadalafil—Skin disorder—Docetaxel—lung cancer	0.000211	0.0005	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000211	0.000499	CcSEcCtD
Tadalafil—Hypersensitivity—Cisplatin—lung cancer	0.00021	0.000498	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—CREBBP—lung cancer	0.00021	0.00204	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Paclitaxel—lung cancer	0.00021	0.000496	CcSEcCtD
Tadalafil—Diarrhoea—Gemcitabine—lung cancer	0.00021	0.000496	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—AVP—lung cancer	0.000209	0.00203	CbGpPWpGaD
Tadalafil—Renal failure—Doxorubicin—lung cancer	0.000209	0.000495	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—lung cancer	0.000209	0.000494	CcSEcCtD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000208	0.00202	CbGpPWpGaD
Tadalafil—Dizziness—Irinotecan—lung cancer	0.000208	0.000492	CcSEcCtD
Tadalafil—Urticaria—Etoposide—lung cancer	0.000208	0.000492	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—lung cancer	0.000207	0.000489	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—lung cancer	0.000207	0.000489	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—lung cancer	0.000207	0.000489	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000207	0.00201	CbGpPWpGaD
Tadalafil—Eye disorder—Methotrexate—lung cancer	0.000206	0.000488	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—lung cancer	0.000206	0.000487	CcSEcCtD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000206	0.002	CbGpPWpGaD
Tadalafil—Asthenia—Cisplatin—lung cancer	0.000205	0.000485	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—lung cancer	0.000205	0.000484	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—lung cancer	0.000204	0.000483	CcSEcCtD
Tadalafil—Urticaria—Paclitaxel—lung cancer	0.000204	0.000482	CcSEcCtD
Tadalafil—Hypotension—Docetaxel—lung cancer	0.000203	0.000481	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—VEGFC—lung cancer	0.000203	0.00197	CbGpPWpGaD
Tadalafil—Haematuria—Doxorubicin—lung cancer	0.000203	0.00048	CcSEcCtD
Tadalafil—Abdominal pain—Paclitaxel—lung cancer	0.000203	0.00048	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000201	0.00195	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000201	0.00195	CbGpPWpGaD
Tadalafil—Epistaxis—Doxorubicin—lung cancer	0.000201	0.000475	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—lung cancer	0.0002	0.000474	CcSEcCtD
Tadalafil—Vomiting—Irinotecan—lung cancer	0.0002	0.000473	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—RAF1—lung cancer	0.0002	0.00194	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CD—lung cancer	0.000199	0.00194	CbGpPWpGaD
Tadalafil—Immune system disorder—Methotrexate—lung cancer	0.000199	0.000471	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—lung cancer	0.000199	0.00047	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000199	0.00193	CbGpPWpGaD
Tadalafil—Rash—Irinotecan—lung cancer	0.000198	0.000469	CcSEcCtD
Tadalafil—Dermatitis—Irinotecan—lung cancer	0.000198	0.000469	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000198	0.000469	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000198	0.00192	CbGpPWpGaD
Tadalafil—Headache—Irinotecan—lung cancer	0.000197	0.000466	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—ALB—lung cancer	0.000197	0.00191	CbGpPWpGaD
Tadalafil—Insomnia—Docetaxel—lung cancer	0.000197	0.000465	CcSEcCtD
Tadalafil—Diarrhoea—Cisplatin—lung cancer	0.000195	0.000462	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—lung cancer	0.000195	0.000462	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—PIK3CB—lung cancer	0.000195	0.0019	CbGpPWpGaD
Tadalafil—Vomiting—Gemcitabine—lung cancer	0.000195	0.000461	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—lung cancer	0.000194	0.000459	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—lung cancer	0.000193	0.000457	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—lung cancer	0.000193	0.000457	CcSEcCtD
Tadalafil—Rash—Gemcitabine—lung cancer	0.000193	0.000457	CcSEcCtD
Tadalafil—Dermatitis—Gemcitabine—lung cancer	0.000193	0.000457	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—lung cancer	0.000193	0.000456	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—lung cancer	0.000192	0.000454	CcSEcCtD
Tadalafil—Headache—Gemcitabine—lung cancer	0.000192	0.000454	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ADCY1—lung cancer	0.000192	0.00186	CbGpPWpGaD
Tadalafil—Rhinitis—Doxorubicin—lung cancer	0.000192	0.000453	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—lung cancer	0.000191	0.000453	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—lung cancer	0.000191	0.000452	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—lung cancer	0.00019	0.00045	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—lung cancer	0.00019	0.000449	CcSEcCtD
Tadalafil—Hypersensitivity—Paclitaxel—lung cancer	0.000189	0.000447	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—lung cancer	0.000189	0.000446	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—lung cancer	0.000188	0.000445	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—lung cancer	0.000188	0.000444	CcSEcCtD
Tadalafil—Asthenia—Etoposide—lung cancer	0.000188	0.000444	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—lung cancer	0.000188	0.000444	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—lung cancer	0.000188	0.000444	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—lung cancer	0.000187	0.000443	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—SMARCA4—lung cancer	0.000187	0.00182	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PPP2R1B—lung cancer	0.000187	0.00182	CbGpPWpGaD
Tadalafil—Nausea—Irinotecan—lung cancer	0.000187	0.000442	CcSEcCtD
Tadalafil—Constipation—Docetaxel—lung cancer	0.000186	0.00044	CcSEcCtD
Tadalafil—Pain—Docetaxel—lung cancer	0.000186	0.00044	CcSEcCtD
Tadalafil—Back pain—Methotrexate—lung cancer	0.000186	0.00044	CcSEcCtD
Tadalafil—Pruritus—Etoposide—lung cancer	0.000185	0.000438	CcSEcCtD
Tadalafil—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000185	0.0018	CbGpPWpGaD
Tadalafil—Asthenia—Paclitaxel—lung cancer	0.000184	0.000436	CcSEcCtD
Tadalafil—Nausea—Gemcitabine—lung cancer	0.000182	0.000431	CcSEcCtD
Tadalafil—Vomiting—Cisplatin—lung cancer	0.000182	0.00043	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000182	0.00176	CbGpPWpGaD
Tadalafil—Pruritus—Paclitaxel—lung cancer	0.000182	0.000429	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—lung cancer	0.000181	0.000428	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—lung cancer	0.000181	0.000427	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HSPB1—lung cancer	0.00018	0.00175	CbGpPWpGaD
Tadalafil—Rash—Cisplatin—lung cancer	0.00018	0.000426	CcSEcCtD
Tadalafil—Dermatitis—Cisplatin—lung cancer	0.00018	0.000426	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—IL2—lung cancer	0.000179	0.00174	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000179	0.00174	CbGpPWpGaD
Tadalafil—Diarrhoea—Etoposide—lung cancer	0.000179	0.000424	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—lung cancer	0.000179	0.000422	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PTHLH—lung cancer	0.000178	0.00173	CbGpPWpGaD
Tadalafil—Tinnitus—Doxorubicin—lung cancer	0.000178	0.000421	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—RAF1—lung cancer	0.000178	0.00173	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Docetaxel—lung cancer	0.000178	0.000421	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—lung cancer	0.000177	0.000419	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—lung cancer	0.000177	0.000419	CcSEcCtD
Tadalafil—Diarrhoea—Paclitaxel—lung cancer	0.000176	0.000415	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—PIK3CB—lung cancer	0.000174	0.00169	CbGpPWpGaD
Tadalafil—Angiopathy—Doxorubicin—lung cancer	0.000173	0.00041	CcSEcCtD
Tadalafil—Dizziness—Etoposide—lung cancer	0.000173	0.000409	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—lung cancer	0.000173	0.000408	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—lung cancer	0.000173	0.000408	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—lung cancer	0.000172	0.000407	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—lung cancer	0.000172	0.000407	CcSEcCtD
Tadalafil—Dizziness—Paclitaxel—lung cancer	0.00017	0.000401	CcSEcCtD
Tadalafil—Nausea—Cisplatin—lung cancer	0.00017	0.000401	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000169	0.00164	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ANXA1—lung cancer	0.000168	0.00163	CbGpPWpGaD
Tadalafil—Cough—Methotrexate—lung cancer	0.000168	0.000397	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—lung cancer	0.000167	0.000396	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—lung cancer	0.000166	0.000394	CcSEcCtD
Tadalafil—Vomiting—Etoposide—lung cancer	0.000166	0.000394	CcSEcCtD
Tadalafil—Rash—Etoposide—lung cancer	0.000165	0.00039	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—lung cancer	0.000165	0.00039	CcSEcCtD
Tadalafil—Headache—Etoposide—lung cancer	0.000164	0.000388	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—lung cancer	0.000164	0.000387	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—lung cancer	0.000164	0.000387	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—lung cancer	0.000164	0.000387	CcSEcCtD
Tadalafil—Vomiting—Paclitaxel—lung cancer	0.000163	0.000386	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000162	0.000384	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—FLT1—lung cancer	0.000162	0.00158	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000162	0.00157	CbGpPWpGaD
Tadalafil—Rash—Paclitaxel—lung cancer	0.000162	0.000383	CcSEcCtD
Tadalafil—Dermatitis—Paclitaxel—lung cancer	0.000162	0.000382	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—lung cancer	0.000162	0.000382	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—lung cancer	0.000161	0.000381	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CG—lung cancer	0.000161	0.00156	CbGpPWpGaD
Tadalafil—Headache—Paclitaxel—lung cancer	0.000161	0.00038	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—EP300—lung cancer	0.000161	0.00156	CbGpPWpGaD
Tadalafil—Hypersensitivity—Docetaxel—lung cancer	0.00016	0.000379	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—lung cancer	0.00016	0.000378	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—IL2—lung cancer	0.00016	0.00155	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.00016	0.00155	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NOTCH3—lung cancer	0.000159	0.00154	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APP—lung cancer	0.000159	0.00154	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—FGF9—lung cancer	0.000158	0.00153	CbGpPWpGaD
Tadalafil—Vision blurred—Doxorubicin—lung cancer	0.000157	0.000371	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—SRC—lung cancer	0.000156	0.00152	CbGpPWpGaD
Tadalafil—Asthenia—Docetaxel—lung cancer	0.000156	0.000369	CcSEcCtD
Tadalafil—Infection—Methotrexate—lung cancer	0.000156	0.000368	CcSEcCtD
Tadalafil—Nausea—Etoposide—lung cancer	0.000155	0.000368	CcSEcCtD
Tadalafil—Pruritus—Docetaxel—lung cancer	0.000154	0.000364	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—lung cancer	0.000154	0.000364	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—POMC—lung cancer	0.000153	0.00149	CbGpPWpGaD
Tadalafil—Nausea—Paclitaxel—lung cancer	0.000152	0.000361	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—lung cancer	0.000152	0.00036	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—VEGFA—lung cancer	0.000152	0.00148	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Methotrexate—lung cancer	0.000152	0.000358	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—JUNB—lung cancer	0.000151	0.00146	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—NRAS—lung cancer	0.00015	0.00146	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.00015	0.00145	CbGpPWpGaD
Tadalafil—Vertigo—Doxorubicin—lung cancer	0.000149	0.000353	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—lung cancer	0.000149	0.000353	CcSEcCtD
Tadalafil—Diarrhoea—Docetaxel—lung cancer	0.000149	0.000352	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000148	0.00144	CbGpPWpGaD
Tadalafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000148	0.00144	CbGpPWpGaD
Tadalafil—Palpitations—Doxorubicin—lung cancer	0.000147	0.000348	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—lung cancer	0.000146	0.000347	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—lung cancer	0.000146	0.000346	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CG—lung cancer	0.000146	0.00142	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000146	0.00142	CbGpPWpGaD
Tadalafil—Cough—Doxorubicin—lung cancer	0.000145	0.000343	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000144	0.0014	CbGpPWpGaD
Tadalafil—Convulsion—Doxorubicin—lung cancer	0.000144	0.000341	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—MAPK3—lung cancer	0.000144	0.0014	CbGpPWpGaD
Tadalafil—Dizziness—Docetaxel—lung cancer	0.000144	0.00034	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—lung cancer	0.000144	0.00034	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—EP300—lung cancer	0.000143	0.00139	CbGpPWpGaD
Tadalafil—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000143	0.000338	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—lung cancer	0.000142	0.000335	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—lung cancer	0.000142	0.000335	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—lung cancer	0.000142	0.000335	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—lung cancer	0.000142	0.000335	CcSEcCtD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CD—lung cancer	0.000141	0.00137	CbGpPWpGaD
Tadalafil—Paraesthesia—Methotrexate—lung cancer	0.000141	0.000333	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000141	0.000333	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—lung cancer	0.00014	0.000331	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—lung cancer	0.00014	0.000331	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—lung cancer	0.000139	0.00033	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—SRC—lung cancer	0.000139	0.00135	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000139	0.00135	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—POMC—lung cancer	0.000139	0.00135	CbGpPWpGaD
Tadalafil—Dry mouth—Doxorubicin—lung cancer	0.000138	0.000328	CcSEcCtD
Tadalafil—Vomiting—Docetaxel—lung cancer	0.000138	0.000327	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—lung cancer	0.000138	0.000326	CcSEcCtD
Tadalafil—Rash—Docetaxel—lung cancer	0.000137	0.000324	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—lung cancer	0.000137	0.000324	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—STK11—lung cancer	0.000137	0.00133	CbGpPWpGaD
Tadalafil—Headache—Docetaxel—lung cancer	0.000136	0.000322	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—lung cancer	0.000136	0.000321	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—VEGFA—lung cancer	0.000136	0.00132	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6R—lung cancer	0.000136	0.00132	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Methotrexate—lung cancer	0.000135	0.00032	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—lung cancer	0.000135	0.00032	CcSEcCtD
Tadalafil—Infection—Doxorubicin—lung cancer	0.000135	0.000319	CcSEcCtD
Tadalafil—Pain—Methotrexate—lung cancer	0.000134	0.000317	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—NRAS—lung cancer	0.000134	0.0013	CbGpPWpGaD
Tadalafil—Shock—Doxorubicin—lung cancer	0.000134	0.000316	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—lung cancer	0.000133	0.000315	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—lung cancer	0.000132	0.000313	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—FOXO3—lung cancer	0.000132	0.00128	CbGpPWpGaD
Tadalafil—Skin disorder—Doxorubicin—lung cancer	0.000132	0.000312	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000131	0.00128	CbGpPWpGaD
Tadalafil—Hyperhidrosis—Doxorubicin—lung cancer	0.000131	0.00031	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—KRAS—lung cancer	0.000129	0.00126	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000129	0.00126	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—MAP2K1—lung cancer	0.000129	0.00126	CbGpPWpGaD
Tadalafil—Nausea—Docetaxel—lung cancer	0.000129	0.000306	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CD—lung cancer	0.000128	0.00125	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—MAPK3—lung cancer	0.000128	0.00125	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Methotrexate—lung cancer	0.000128	0.000303	CcSEcCtD
Tadalafil—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000128	0.00124	CbGpPWpGaD
Tadalafil—Hypotension—Doxorubicin—lung cancer	0.000127	0.0003	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—lung cancer	0.000125	0.000295	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—lung cancer	0.000124	0.000293	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000124	0.000293	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—AVP—lung cancer	0.000124	0.0012	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CB—lung cancer	0.000123	0.0012	CbGpPWpGaD
Tadalafil—Insomnia—Doxorubicin—lung cancer	0.000123	0.00029	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—lung cancer	0.000122	0.000288	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000121	0.00118	CbGpPWpGaD
Tadalafil—Dyspnoea—Doxorubicin—lung cancer	0.000121	0.000286	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—lung cancer	0.000121	0.000285	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—lung cancer	0.000119	0.000283	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—IGF1R—lung cancer	0.000119	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—PIK3CA—lung cancer	0.000119	0.00116	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—CXCL8—lung cancer	0.000118	0.00115	CbGpPWpGaD
Tadalafil—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000117	0.000277	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—lung cancer	0.000117	0.000277	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—HES1—lung cancer	0.000117	0.00114	CbGpPWpGaD
Tadalafil—Constipation—Doxorubicin—lung cancer	0.000116	0.000275	CcSEcCtD
Tadalafil—Pain—Doxorubicin—lung cancer	0.000116	0.000275	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—lung cancer	0.000115	0.000273	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—KRAS—lung cancer	0.000115	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—TP53—lung cancer	0.000115	0.00112	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—RAF1—lung cancer	0.000115	0.00111	CbGpPWpGaD
Tadalafil—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000114	0.00111	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—IL2—lung cancer	0.000113	0.0011	CbGpPWpGaD
Tadalafil—Asthenia—Methotrexate—lung cancer	0.000112	0.000266	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CB—lung cancer	0.000112	0.00109	CbGpPWpGaD
Tadalafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000112	0.00108	CbGpPWpGaD
Tadalafil—Gastrointestinal pain—Doxorubicin—lung cancer	0.000111	0.000263	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—lung cancer	0.000111	0.000262	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.00011	0.00107	CbGpPWpGaD
Tadalafil—PDE11A—Hemostasis—HRAS—lung cancer	0.00011	0.00107	CbGpPWpGaD
Tadalafil—Urticaria—Doxorubicin—lung cancer	0.000108	0.000255	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—CXCL8—lung cancer	0.000108	0.00105	CbGpPWpGaD
Tadalafil—Abdominal pain—Doxorubicin—lung cancer	0.000107	0.000254	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—lung cancer	0.000107	0.000254	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—ERBB3—lung cancer	0.000107	0.00104	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000107	0.00104	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—PIK3CA—lung cancer	0.000106	0.00103	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.000105	0.00103	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GCLC—lung cancer	0.000105	0.00103	CbGpPWpGaD
Tadalafil—Dizziness—Methotrexate—lung cancer	0.000104	0.000245	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—IL2—lung cancer	0.000103	0.000999	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—TP53—lung cancer	0.000103	0.000996	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TERT—lung cancer	0.000102	0.000996	CbGpPWpGaD
Tadalafil—Hypersensitivity—Doxorubicin—lung cancer	0.0001	0.000237	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—lung cancer	9.97e-05	0.000236	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—FGFR1—lung cancer	9.95e-05	0.000967	CbGpPWpGaD
Tadalafil—Rash—Methotrexate—lung cancer	9.88e-05	0.000234	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—lung cancer	9.88e-05	0.000234	CcSEcCtD
Tadalafil—Headache—Methotrexate—lung cancer	9.82e-05	0.000232	CcSEcCtD
Tadalafil—PDE5A—Hemostasis—HRAS—lung cancer	9.81e-05	0.000953	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HIF1A—lung cancer	9.8e-05	0.000952	CbGpPWpGaD
Tadalafil—Asthenia—Doxorubicin—lung cancer	9.74e-05	0.00023	CcSEcCtD
Tadalafil—PDE11A—Hemostasis—AKT1—lung cancer	9.71e-05	0.000944	CbGpPWpGaD
Tadalafil—Pruritus—Doxorubicin—lung cancer	9.6e-05	0.000227	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—APOA1—lung cancer	9.45e-05	0.000919	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KDR—lung cancer	9.37e-05	0.000911	CbGpPWpGaD
Tadalafil—Nausea—Methotrexate—lung cancer	9.31e-05	0.00022	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—lung cancer	9.29e-05	0.00022	CcSEcCtD
Tadalafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.04e-05	0.000879	CbGpPWpGaD
Tadalafil—Dizziness—Doxorubicin—lung cancer	8.98e-05	0.000212	CcSEcCtD
Tadalafil—CYP3A4—Biological oxidations—CYP2E1—lung cancer	8.97e-05	0.000872	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	8.85e-05	0.00086	CbGpPWpGaD
Tadalafil—PDE5A—Hemostasis—AKT1—lung cancer	8.66e-05	0.000841	CbGpPWpGaD
Tadalafil—Vomiting—Doxorubicin—lung cancer	8.63e-05	0.000204	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—PIK3CG—lung cancer	8.63e-05	0.000839	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—APC—lung cancer	8.63e-05	0.000839	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KIT—lung cancer	8.63e-05	0.000839	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—NRAS—lung cancer	8.63e-05	0.000839	CbGpPWpGaD
Tadalafil—Rash—Doxorubicin—lung cancer	8.56e-05	0.000202	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—lung cancer	8.55e-05	0.000202	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—EGF—lung cancer	8.53e-05	0.000829	CbGpPWpGaD
Tadalafil—Headache—Doxorubicin—lung cancer	8.5e-05	0.000201	CcSEcCtD
Tadalafil—PDE11A—Signaling by GPCR—MAPK3—lung cancer	8.26e-05	0.000803	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—POMC—lung cancer	8.21e-05	0.000798	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—BRAF—lung cancer	8.11e-05	0.000788	CbGpPWpGaD
Tadalafil—Nausea—Doxorubicin—lung cancer	8.06e-05	0.000191	CcSEcCtD
Tadalafil—PDE11A—Signaling Pathways—IL6R—lung cancer	8.01e-05	0.000779	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CREBBP—lung cancer	8e-05	0.000778	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—EGFR—lung cancer	7.86e-05	0.000764	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAP2K1—lung cancer	7.64e-05	0.000742	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CD—lung cancer	7.59e-05	0.000737	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—PIK3CA—lung cancer	7.51e-05	0.00073	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—KRAS—lung cancer	7.43e-05	0.000722	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTP1—lung cancer	7.4e-05	0.000719	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	7.29e-05	0.000709	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—PIK3CA—lung cancer	6.82e-05	0.000663	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—GSTM1—lung cancer	6.8e-05	0.000661	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MDM2—lung cancer	6.8e-05	0.000661	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—RAF1—lung cancer	6.77e-05	0.000658	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	6.7e-05	0.000652	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—ERBB2—lung cancer	6.7e-05	0.000651	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MTOR—lung cancer	6.61e-05	0.000643	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CB—lung cancer	6.61e-05	0.000643	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—CYP1A1—lung cancer	6.44e-05	0.000626	CbGpPWpGaD
Tadalafil—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	6.35e-05	0.000618	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CXCL8—lung cancer	6.35e-05	0.000618	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—HRAS—lung cancer	6.31e-05	0.000614	CbGpPWpGaD
Tadalafil—PDE11A—GPCR downstream signaling—AKT1—lung cancer	6.14e-05	0.000597	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CASP3—lung cancer	6.08e-05	0.000591	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL2—lung cancer	6.07e-05	0.00059	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—IL6—lung cancer	6.04e-05	0.000587	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CCND1—lung cancer	5.92e-05	0.000575	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—JUN—lung cancer	5.91e-05	0.000574	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MMP9—lung cancer	5.75e-05	0.000559	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—CDKN1A—lung cancer	5.73e-05	0.000557	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PTEN—lung cancer	5.71e-05	0.000555	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.67e-05	0.000551	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AZIN2—lung cancer	5.67e-05	0.000551	CbGpPWpGaD
Tadalafil—PDE11A—Signaling by GPCR—AKT1—lung cancer	5.57e-05	0.000542	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EP300—lung cancer	5.45e-05	0.00053	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—SRC—lung cancer	5.3e-05	0.000515	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—VEGFA—lung cancer	5.16e-05	0.000502	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—STAT3—lung cancer	5.11e-05	0.000497	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—NRAS—lung cancer	5.1e-05	0.000495	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MAPK3—lung cancer	4.88e-05	0.000475	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ATP5H—lung cancer	4.82e-05	0.000468	CbGpPWpGaD
Tadalafil—CYP3A4—Biological oxidations—POMC—lung cancer	4.8e-05	0.000467	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—MYC—lung cancer	4.75e-05	0.000462	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—EGFR—lung cancer	4.64e-05	0.000451	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—KRAS—lung cancer	4.39e-05	0.000426	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PLBD1—lung cancer	4.3e-05	0.000417	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—PIK3CA—lung cancer	4.03e-05	0.000392	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HSD17B10—lung cancer	3.93e-05	0.000382	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—TP53—lung cancer	3.9e-05	0.000379	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—HRAS—lung cancer	3.73e-05	0.000362	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CKB—lung cancer	3.65e-05	0.000355	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—IL6—lung cancer	3.57e-05	0.000347	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM2—lung cancer	3.43e-05	0.000334	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CNDP2—lung cancer	3.43e-05	0.000334	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—MTMR3—lung cancer	3.34e-05	0.000325	CbGpPWpGaD
Tadalafil—PDE11A—Signaling Pathways—AKT1—lung cancer	3.29e-05	0.00032	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PGAM1—lung cancer	3.26e-05	0.000316	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2A7—lung cancer	3.11e-05	0.000302	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—SDC4—lung cancer	3.04e-05	0.000295	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—RRM1—lung cancer	2.77e-05	0.000269	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA3—lung cancer	2.77e-05	0.000269	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—B4GALT5—lung cancer	2.6e-05	0.000253	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA4—lung cancer	2.53e-05	0.000246	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA2—lung cancer	2.47e-05	0.00024	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTA1—lung cancer	2.38e-05	0.000231	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCC3—lung cancer	2.35e-05	0.000229	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKR1C1—lung cancer	2.28e-05	0.000222	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—UGT1A1—lung cancer	2.21e-05	0.000215	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GNG11—lung cancer	2.13e-05	0.000207	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALDOA—lung cancer	2.03e-05	0.000197	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NCOA3—lung cancer	1.97e-05	0.000192	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ADCY1—lung cancer	1.92e-05	0.000186	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCG2—lung cancer	1.92e-05	0.000186	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENO2—lung cancer	1.88e-05	0.000183	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—HPGDS—lung cancer	1.88e-05	0.000183	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.87e-05	0.000182	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTT1—lung cancer	1.82e-05	0.000177	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GCLC—lung cancer	1.8e-05	0.000175	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2A6—lung cancer	1.8e-05	0.000175	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ENO1—lung cancer	1.71e-05	0.000166	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP2E1—lung cancer	1.53e-05	0.000149	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—NQO1—lung cancer	1.52e-05	0.000147	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—STK11—lung cancer	1.37e-05	0.000133	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTP1—lung cancer	1.26e-05	0.000123	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CAT—lung cancer	1.23e-05	0.00012	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ABCB1—lung cancer	1.2e-05	0.000116	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—TYMS—lung cancer	1.18e-05	0.000114	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—GSTM1—lung cancer	1.16e-05	0.000113	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CYP1A1—lung cancer	1.1e-05	0.000107	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ERCC2—lung cancer	1.09e-05	0.000106	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—APOA1—lung cancer	9.45e-06	9.19e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CG—lung cancer	8.63e-06	8.39e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—POMC—lung cancer	8.22e-06	7.98e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—CREBBP—lung cancer	8e-06	7.78e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CD—lung cancer	7.59e-06	7.37e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—ALB—lung cancer	7.49e-06	7.28e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CB—lung cancer	6.61e-06	6.43e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTGS2—lung cancer	6.55e-06	6.37e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PTEN—lung cancer	5.71e-06	5.55e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—EP300—lung cancer	5.45e-06	5.3e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—PIK3CA—lung cancer	4.03e-06	3.92e-05	CbGpPWpGaD
Tadalafil—CYP3A4—Metabolism—AKT1—lung cancer	3.29e-06	3.2e-05	CbGpPWpGaD
